Physician profile
Thomas A St John
NPI 1710941851
$3,027.26
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $992 · 2021: $424 · 2022: $231 · 2023: $25.01 · 2024: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $684 · Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $684.27 |
| Food and Beverage | $325.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,224.45 | 2019-2024 | Mako, Triathlon, Vitoss |
| Zimmer Biomet Holdings, INC. | $392.77 | 2019-2024 | Rosa |
| Si-Bone, INC. | $182.79 | 2021-2022 | |
| Seapearl East, INC | $97.95 | 2020 | |
| Akcea Therapeutics, INC. | $16.66 | 2019 | |
| Promius Pharma LLC | $14.92 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.89 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.33 | 2019 | |
| Adamas Pharmaceuticals, INC. | $14.08 | 2019 | |
| Daiichi Sankyo INC. | $13.85 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.76 | 2020 | |
| Alexion Pharmaceuticals, INC. | $13.50 | 2019 | |
| Kyowa Kirin, INC. | $13.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas St John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.